Replies to post #75059 on NorthWest Biotherapeutics Inc (NWBO)

[spartex]

nearly ALL patients in this trial which are using DCVAXL are living over double SOC.

Can that kind of potential efficacy be translated into stock value/market cap if approved? Thanks md!

[slappdaddy]

So, you can release this info but NWBO can't. That doesn't seem right.

[bullrider2]

I agree their are living longer. I'am just waiting for NorthWest bio to release this information. And what about the patients that has been in the continue trial studies for 11 years. What is the update on their progress, and are they still cancer free. Plus have there been other patients who has reach this level of prognosis. This info should be updated and made available on the companies website. We need more than just a simple pr.

[austinmediainc]

ALL patients in this trial which are using DCVAXL are living over double SOC

That's talent....knowing OS in a double blinded trial? Surprised this is only trading at .60....what a conspiracy.....or maybe the information is false?